Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 31, 2026
Brookfield Corporation (BN) Shows Resilience with +7% Year-over-Year Growth in DE Before Realizations

Brookfield Corporation (BN) Shows Resilience with +7% Year-over-Year Growth in DE Before Realizations

Key Takeaways

  • Distributable earnings (DE) reached $1.55 billion ($0.66 per share) for the quarter, surpassing the consensus estimate of $0.63 per share.
  • DE before realizations grew 7% year-over-year to $1.39 billion ($0.59 per share), driven by strength across asset management and wealth solutions.
  • Year-to-date fundraising surged to $67 billion, including a $40 billion investment mandate from Just Group and $6 billion for the seventh flagship private equity strategy.
  • Fee-bearing capital rose 12% to $614 billion, fueling an 11% increase in fee-related earnings.
  • Over $1 billion in combined BN and BAM shares were repurchased year-to-date, with management citing a roughly 40% discount to intrinsic value.
  • Quarterly dividend of $0.07 per share was declared, and the company closed the Just Group acquisition after quarter-end, expanding insurance assets by $40 billion.

Why These Results Matter Now

Brookfield Corporation's (BN) first-quarter results landed at a pivotal moment for the alternative asset management industry. With global markets navigating elevated interest rates, geopolitical uncertainty, and shifting investor demand toward real assets, the Q1 2026 report offered a timely read on institutional capital flows and the resilience of its diversified business model. The quarter demonstrated continued momentum in fundraising, steady cash flows from operating businesses, and a rapidly scaling wealth solutions platform. In my view, these results provided critical evidence of whether Brookfield's strategy of combining asset management, insurance, and direct investments can sustain growth through economic cycles — a question central to the stock's valuation trajectory. I also checked this using Tickeron's AI Screener to see how the stock compares to others in the industry.

The Quarter's Key Numbers

Brookfield Corporation (BN) reported total distributable earnings (DE) — a non-IFRS metric the company uses to measure cash available for distribution or reinvestment — of $1.55 billion, or $0.66 per share, for the first quarter ended March 31, 2026. This exceeded the analyst consensus estimate of $0.63 per share. DE before realizations, which excludes gains from asset sales and carried interest, came in at $1.39 billion ($0.59 per share), representing a 7% increase on a per-share basis compared to the same quarter last year.

On a consolidated IFRS basis, net income totaled $1.04 billion, a sharp increase from $215 million in the prior-year period, largely reflecting fair value changes and equity-accounted income. Net income attributable to Brookfield shareholders was $102 million ($0.03 per diluted share). The company's asset management segment generated $765 million in DE, wealth solutions contributed $430 million, and operating businesses — spanning infrastructure, energy, private equity, and real estate — delivered $360 million. Fee-bearing capital reached $614 billion, up 12% year-over-year, supporting an 11% increase in fee-related earnings.

The company also reported $17 billion in asset monetizations during the quarter across infrastructure, energy, real estate, and other holdings, with substantially all sales completed at or above carrying values. Accumulated unrealized carried interest stood at $11.8 billion at quarter-end.

Market Response and Analyst Views

Brookfield shares, which traded near $46 in mid-May 2026 around the time of the Q1 earnings release, have since drifted lower alongside broader alternative asset manager stocks, closing at approximately $42 by late July. The decline reflected a mix of macro-driven pressure on the sector — including concerns around private credit valuations and software exposure at peer firms — rather than company-specific disappointment. During the earnings call, management explicitly addressed these sector-wide concerns, noting that Brookfield has "no software exposure" and that its credit portfolio continues to perform well. Analysts have maintained a broadly constructive view, with an average price target of approximately $54 and a consensus "Overweight" rating, suggesting that the market's pullback may reflect sector rotation rather than deteriorating fundamentals. The company's aggressive share repurchase activity — $470 million of BN shares year-to-date at an average price of $41 — further signaled management's conviction in the stock's undervaluation relative to its stated intrinsic value of $66 per share.

Looking Ahead: Key Catalysts

Looking ahead, several developments will shape the investment narrative around Brookfield Corporation (BN) through the remainder of 2026. The most immediate catalyst is the planned corporate combination of Brookfield Corporation (BN) and its insurance business, Brookfield Wealth Solutions (BNT). Management confirmed that boards of both entities are expected to conduct a final review in the coming weeks, with shareholder votes anticipated. This simplification, which follows the successful conversion of BBUC earlier in the year, aims to enhance capital efficiency and give insurance operations direct access to Brookfield's $145 billion permanent capital base.

On the operational front, the completion of the Just Group acquisition on April 1, 2026, meaningfully expands Brookfield's U.K. retirement and annuity footprint, adding $40 billion in insurance assets and bringing total insurance assets to $180 billion. Investors will watch for early integration metrics and the pace of annuity origination in the Q2 report. Additionally, Brookfield expects to finalize the first close of its seventh vintage flagship private equity strategy in the coming months, which could further accelerate fundraising totals already running at a record pace.

The real estate portfolio also warrants close monitoring. With super core and core plus occupancy rates above 95% and new office leases being signed at rents 15% above expiring levels, Brookfield's high-quality property portfolio continues to differentiate itself. However, broader commercial real estate headwinds and interest rate uncertainty remain risk factors. The company's $188 billion in deployable capital provides substantial dry powder for opportunistic deployment, though the pace and scale of capital deployment will be a key barometer of management's conviction in the investment environment during the second half of 2026.

Enhancing Research with AI Tools

In my regular research process, I turn to Tickeron's AI Screener to quickly filter opportunities and benchmark names like Brookfield against peers using customizable criteria and AI signals. This helps surface relevant comparisons without getting lost in the data. The platform supports more efficient screening for both fundamental and technical ideas.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BN

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


BN in downward trend: 10-day moving average broke below 50-day moving average on August 21, 2026

The 10-day moving average for BN crossed bearishly below the 50-day moving average on August 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BN as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BN turned negative on August 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

BN moved below its 50-day moving average on August 17, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BN's RSI Indicator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BN advanced for three days, in of 343 cases, the price rose further within the following month. The odds of a continued upward trend are .

BN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 289 cases where BN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.191) is normal, around the industry mean (3.525). BN has a moderately high P/E Ratio (77.204) as compared to the industry average of (27.186). BN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.208). BN has a moderately low Dividend Yield (0.006) as compared to the industry average of (0.086). P/S Ratio (1.278) is also within normal values, averaging (16.512).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Ares Capital Corp (NASDAQ:ARCC), WisdomTree (NYSE:WT), AMTD IDEA Group (NYSE:AMTD).

Industry description

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

Market Cap

The average market capitalization across the Investment Managers Industry is 9.63B. The market cap for tickers in the group ranges from 57 to 179.11B. BLK holds the highest valuation in this group at 179.11B. The lowest valued company is RSERF at 57.

High and low price notable news

The average weekly price growth across all stocks in the Investment Managers Industry was 2%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was 5%. ZSTK experienced the highest price growth at 143%, while AMBR experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Investment Managers Industry was -4%. For the same stocks of the Industry, the average monthly volume growth was 25% and the average quarterly volume growth was -53%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 33
P/E Growth Rating: 55
Price Growth Rating: 51
SMR Rating: 74
Profit Risk Rating: 78
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
BN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an alternative asset manager which owns, manages and operates real estate, financial and power generation related businesses

Industry InvestmentManagers

Profile
Details
Industry
Investment Managers
Address
181 Bay Street
Phone
+1 416 363-9491
Employees
242400
Web
https://www.brookfield.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.